EBM — Eastwood Bio-Medical Canada Share Price
- CA$30.31m
- CA$30.38m
- CA$0.70m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 42.34 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -61.84% |
Financial Summary
Year End 31st Oct | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | 0.72 | 0.98 | 1.3 | 0.87 | 0.7 | n/a | n/a | -11.5% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Eastwood Bio-Medical Canada Inc. is a Canada-based company, which is engaged in marketing and distributing natural health products in North America. The Company is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. The Company's Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. Its licensed products which have secured Health Canada product license numbers include Eleotin A 700, Eleotin AL88, Eleotin Cal20, Eleotin V3D, Eleotin G2000, Eleotin H55, and Eleotin Zn330. Additionally, Eleotin Bentley and Eleotin LBM have received Health Canada product license numbers. The Eleotin Bentley is used to promote healthy glucose levels. The Eleotin LBM is recommended for hypertension relief. The Company markets its products in Asia, United States and Canada.
Directors
- Last Annual
- October 31st, 2024
- Last Interim
- January 31st, 2025
- Incorporated
- December 10th, 2010
- Public Since
- September 5th, 2014
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
TSX Venture Exchange
- Shares in Issue
- 68,885,969

- Address
- 1130 - 4871 Shell Road, RICHMOND, V6X 3Z6
- Web
- https://eleotin.ca/
- Phone
- +1 6042472100
- Auditors
- Saturna Group Chartered Professional Accountants LLP
Upcoming Events for EBM
Similar to EBM
Aequus Pharmaceuticals
TSX Venture Exchange
Arch Biopartners
TSX Venture Exchange
Biosyent
TSX Venture Exchange
Cytophage Technologies
TSX Venture Exchange
Decibel Cannabis
TSX Venture Exchange
FAQ
As of Today at 20:21 UTC, shares in Eastwood Bio-Medical Canada are trading at CA$0.44. This share price information is delayed by 15 minutes.
Shares in Eastwood Bio-Medical Canada last closed at CA$0.44 and the price had moved by -50% over the past 365 days. In terms of relative price strength the Eastwood Bio-Medical Canada share price has underperformed the Toronto Stock Exchange 300 Composite Index by -55.55% over the past year.
There is no consensus recommendation for this security.
Find out moreEastwood Bio-Medical Canada does not currently pay a dividend.
Eastwood Bio-Medical Canada does not currently pay a dividend.
Eastwood Bio-Medical Canada does not currently pay a dividend.
To buy shares in Eastwood Bio-Medical Canada you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.44, shares in Eastwood Bio-Medical Canada had a market capitalisation of CA$30.31m.
Here are the trading details for Eastwood Bio-Medical Canada:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: EBM
Based on an overall assessment of its quality, value and momentum Eastwood Bio-Medical Canada is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eastwood Bio-Medical Canada. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -32.7%.
As of the last closing price of CA$0.44, shares in Eastwood Bio-Medical Canada were trading -35.84% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Eastwood Bio-Medical Canada PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Eastwood Bio-Medical Canada's management team is headed by:
- Yunji Kim - PRE
- Youngsoo Kim - CEO
- Marcus Kuypers - IND
- Ian Mallmann - IND
- Terrance Owen - IND